Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Endothelial dysfunctions and vascular disease [[electronic resource] /] / edited by Raffaele De Caterina, Peter Libby ; foreword by Michael A. Gimbrone Jr
| Endothelial dysfunctions and vascular disease [[electronic resource] /] / edited by Raffaele De Caterina, Peter Libby ; foreword by Michael A. Gimbrone Jr |
| Pubbl/distr/stampa | Malden, MA, : Blackwell Futura, 2007 |
| Descrizione fisica | 1 online resource (432 p.) |
| Disciplina | 616.1/3 |
| Altri autori (Persone) |
De CaterinaR. <1954->
LibbyPeter |
| Soggetto topico |
Blood-vessels - Pathophysiology
Vascular endothelium |
| ISBN |
1-281-32011-0
9786611320119 0-470-98481-3 0-470-98847-9 0-470-99409-6 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Endothelial Dysfunctions and Vascular Disease; Contents; Contributors; Preface; Foreword; Acknowledgments; Dedication; Part I: The basis of endothelial involvement in vascular diseases; 1 Endothelial functions and dysfunctions; 2 Endothelial activation and the initiation of atherosclerosis; 3 Mechanisms of plaque progression and complications; 4 Angiogenesis in cardiovascular disease; Part II: The endothelium and cardiovascular risk factors; 5 VLDL and atherosclerosis; 6 High-density lipoprotein and atheroprotection
7 Advanced glycation endproducts and the accelerated atherosclerosis in diabetes8 Homocysteine and endothelial dysfunction; 9 Lipoprotein(a) and the artery wall; 10 Oxidative stress and vascular disease; 11 Infections and vascular disease; Part III: Diagnostic tools and markers of endothelial functions; 12 Endothelial vasodilatory dysfunction: basic concepts and practical implementation; 13 Endothelial vasodilatory dysfunction and risk factors in adults; 14 Endothelial vasodilatory dysfunction in early life; 15 Endothelial vasodilatory dysfunction in hypertension 16 Vascular function and diabetes mellitus17 Dyslipidemia and endothelial dysfunction: pathophysiology and therapy; 18 Soluble adhesion molecules as in vivo biohumoral markers of vascular cell activation; Part IV: Endothelium-directed prevention and therapy; 19 Hormone replacement therapy and cardiovascular disease; 20 Anti-atherogenic effects of omega-3 fatty acids; 21 Treatment of endothelial dysfunction and atherosclerosis by cholesterol lowering; 22 Antioxidants and endothelial protection 23 Angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers to reverse endothelial dysfunction24 PPARs in atherosclerosis; 25 Stem cells in atherosclerosis and atherosclerosisrelated vascular disorders; 26 Endothelium-targeted gene and cell-based therapy for cardiovascular disease; Index |
| Record Nr. | UNINA-9910145737103321 |
| Malden, MA, : Blackwell Futura, 2007 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Endothelial dysfunctions and vascular disease [[electronic resource] /] / edited by Raffaele De Caterina, Peter Libby ; foreword by Michael A. Gimbrone Jr
| Endothelial dysfunctions and vascular disease [[electronic resource] /] / edited by Raffaele De Caterina, Peter Libby ; foreword by Michael A. Gimbrone Jr |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Malden, MA, : Blackwell Futura, 2007 |
| Descrizione fisica | 1 online resource (432 p.) |
| Disciplina | 616.1/3 |
| Altri autori (Persone) |
De CaterinaR. <1954->
LibbyPeter |
| Soggetto topico |
Blood-vessels - Pathophysiology
Vascular endothelium |
| ISBN |
1-281-32011-0
9786611320119 0-470-98481-3 0-470-98847-9 0-470-99409-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Endothelial Dysfunctions and Vascular Disease; Contents; Contributors; Preface; Foreword; Acknowledgments; Dedication; Part I: The basis of endothelial involvement in vascular diseases; 1 Endothelial functions and dysfunctions; 2 Endothelial activation and the initiation of atherosclerosis; 3 Mechanisms of plaque progression and complications; 4 Angiogenesis in cardiovascular disease; Part II: The endothelium and cardiovascular risk factors; 5 VLDL and atherosclerosis; 6 High-density lipoprotein and atheroprotection
7 Advanced glycation endproducts and the accelerated atherosclerosis in diabetes8 Homocysteine and endothelial dysfunction; 9 Lipoprotein(a) and the artery wall; 10 Oxidative stress and vascular disease; 11 Infections and vascular disease; Part III: Diagnostic tools and markers of endothelial functions; 12 Endothelial vasodilatory dysfunction: basic concepts and practical implementation; 13 Endothelial vasodilatory dysfunction and risk factors in adults; 14 Endothelial vasodilatory dysfunction in early life; 15 Endothelial vasodilatory dysfunction in hypertension 16 Vascular function and diabetes mellitus17 Dyslipidemia and endothelial dysfunction: pathophysiology and therapy; 18 Soluble adhesion molecules as in vivo biohumoral markers of vascular cell activation; Part IV: Endothelium-directed prevention and therapy; 19 Hormone replacement therapy and cardiovascular disease; 20 Anti-atherogenic effects of omega-3 fatty acids; 21 Treatment of endothelial dysfunction and atherosclerosis by cholesterol lowering; 22 Antioxidants and endothelial protection 23 Angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers to reverse endothelial dysfunction24 PPARs in atherosclerosis; 25 Stem cells in atherosclerosis and atherosclerosisrelated vascular disorders; 26 Endothelium-targeted gene and cell-based therapy for cardiovascular disease; Index |
| Record Nr. | UNISA-996208302403316 |
| Malden, MA, : Blackwell Futura, 2007 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Endothelial dysfunctions and vascular disease / / edited by Raffaele De Caterina, Peter Libby ; foreword by Michael A. Gimbrone Jr
| Endothelial dysfunctions and vascular disease / / edited by Raffaele De Caterina, Peter Libby ; foreword by Michael A. Gimbrone Jr |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Malden, MA, : Blackwell Futura, 2007 |
| Descrizione fisica | 1 online resource (432 p.) |
| Disciplina | 616.1/3 |
| Altri autori (Persone) |
De CaterinaR. <1954->
LibbyPeter |
| Soggetto topico |
Blood-vessels - Pathophysiology
Vascular endothelium |
| ISBN |
1-281-32011-0
9786611320119 0-470-98481-3 0-470-98847-9 0-470-99409-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Endothelial Dysfunctions and Vascular Disease; Contents; Contributors; Preface; Foreword; Acknowledgments; Dedication; Part I: The basis of endothelial involvement in vascular diseases; 1 Endothelial functions and dysfunctions; 2 Endothelial activation and the initiation of atherosclerosis; 3 Mechanisms of plaque progression and complications; 4 Angiogenesis in cardiovascular disease; Part II: The endothelium and cardiovascular risk factors; 5 VLDL and atherosclerosis; 6 High-density lipoprotein and atheroprotection
7 Advanced glycation endproducts and the accelerated atherosclerosis in diabetes8 Homocysteine and endothelial dysfunction; 9 Lipoprotein(a) and the artery wall; 10 Oxidative stress and vascular disease; 11 Infections and vascular disease; Part III: Diagnostic tools and markers of endothelial functions; 12 Endothelial vasodilatory dysfunction: basic concepts and practical implementation; 13 Endothelial vasodilatory dysfunction and risk factors in adults; 14 Endothelial vasodilatory dysfunction in early life; 15 Endothelial vasodilatory dysfunction in hypertension 16 Vascular function and diabetes mellitus17 Dyslipidemia and endothelial dysfunction: pathophysiology and therapy; 18 Soluble adhesion molecules as in vivo biohumoral markers of vascular cell activation; Part IV: Endothelium-directed prevention and therapy; 19 Hormone replacement therapy and cardiovascular disease; 20 Anti-atherogenic effects of omega-3 fatty acids; 21 Treatment of endothelial dysfunction and atherosclerosis by cholesterol lowering; 22 Antioxidants and endothelial protection 23 Angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers to reverse endothelial dysfunction24 PPARs in atherosclerosis; 25 Stem cells in atherosclerosis and atherosclerosisrelated vascular disorders; 26 Endothelium-targeted gene and cell-based therapy for cardiovascular disease; Index |
| Record Nr. | UNINA-9910824635803321 |
| Malden, MA, : Blackwell Futura, 2007 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Therapeutic Strategies in Thrombosis [[electronic resource]]
| Therapeutic Strategies in Thrombosis [[electronic resource]] |
| Autore | Kristensen S. D. <1955-> |
| Pubbl/distr/stampa | Oxford, : Atlas Medical Publishing Ltd, 2005 |
| Descrizione fisica | 1 online resource (405 p.) |
| Disciplina | 616.13506 |
| Altri autori (Persone) |
De CaterinaR. <1954->
MoliternoDavid J |
| Collana | Therapeutic Strategies |
| Soggetto topico |
Thrombolytic therapy
Thrombosis -- Treatment Thrombosis Cardiovascular Diseases Medicine Health & Biological Sciences |
| ISBN |
1-280-30995-4
9786610309955 1-84692-543-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Contents; Contributors; 1. Arterial thrombosis: a brief overview; 2. Aspirin: a risk-based strategy; 3. Clopidogrel and other platelet ADP inhibitors; 4. Glycoprotein IIb/IIIa inhibitors; 5. Unfractionated heparin and low-molecular-weight heparin in coronary heart disease; 6. Intravenous direct thrombin inhibition: acute coronary syndromes and heparin-induced thrombocytopaenia; 7. Direct thrombin inhibition during percutaneous coronary interventions; 8. Pentasaccharide and other factor Xa inhibitors
9. Direct thrombin inhibition - thromboprophylaxis, deep venous thrombosis, atrial fibrillation and coronary artery disease10. Warfarin after acute myocardial infarction; 11. Thrombolytic therapy and concomitantantithrombotic therapy; 12. Pre-hospital reperfusion therapy; 13. Antithrombotic strategies in patients undergoing primary percutaneous intervention; 14. Antithrombotic management in patients with prosthetic valves; 15. Stroke: thrombolysis and antithrombotic therapy; 16. Atrial fibrillation: antithrombotic therapy; 17, Venous thromboembolism: pathophysiology and diagnosis 18. Antithrombotic therapy in venous thrombosis and pulmonary embolism19.Prevention and treatment of venous and arterial thrombosis in patients with specific conditions: diabetes, hypercoagulable states, pregnancy and renal diseases; 20. Monitoring of antithrombotic drugs; Index |
| Record Nr. | UNISA-996339091403316 |
Kristensen S. D. <1955->
|
||
| Oxford, : Atlas Medical Publishing Ltd, 2005 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||